Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

Myasthenia Gravis ll: Pathophysiology

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evaluation of germline BRCA1 and BRCA2 mutations in a multi-ethnic Asian cohort of ovarian cancer patients.

Gynecologic oncology·2015

Same author

A new 5' terminal murine GAPDH exon identified using 5'RACE LaNe.

Molecular biotechnology·2005

Same journal

Serum GRP78 as a potential biomarker for early liver injury and active fibrogenesis in alcohol-associated liver disease.

Clinical and experimental medicine·2026

Same journal

Beyond polarization: a receptor-centered framework for macrophage function and therapy in skin diseases.

Clinical and experimental medicine·2026

Same journal

UBA2: the gatekeeper of the sumoylation pathway and its multifaceted roles in human diseases and therapeutic prospects.

Clinical and experimental medicine·2026

Same journal

Clonal Metamorphosis: Deconstructing MPN Evolution with Single-Cell and Spatial Multi-Omics.

Clinical and experimental medicine·2026

Same journal

Identifying coagulation-related biomarkers in steroid-induced osteonecrosis of the femoral head: implications for early diagnosis and treatment.

Clinical and experimental medicine·2026

Same journal

KIF7 promotes the proliferation of clear cell renal cell carcinoma by activating the WNT/β-catenin signaling pathway.

Clinical and experimental medicine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

A unifying model for multiple sclerosis.

Daniel Jonathan Park^1,2

¹Melbourne Bioinformatics, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Australia. djp@unimelb.edu.au.

Clinical and Experimental Medicine

|April 30, 2025

Summary

This summary is machine-generated.

This study proposes a new model for multiple sclerosis (MS) where Epstein-Barr virus (EBV) reactivation precedes Human Herpesvirus 6A (HHV-6A) reactivation, potentially explaining MS pathogenesis and guiding future therapies.

Keywords:

Autoantibodies Cytotoxicity Disease model EBV HHV-6A Multiple sclerosis Progressive MS RRMS Viral reactivation

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

Related Experiment Videos

Last Updated: Jun 19, 2026

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

Area of Science:

Neuroimmunology
Viral Pathogenesis
Neurodegenerative Diseases

Background:

Multiple sclerosis (MS) is a complex neurodegenerative disorder with an unknown cause.
Current models often focus on autoimmunity, but face challenges.
Previous hypotheses suggest viral reactivation plays a role in MS.

Purpose of the Study:

To propose an alternative viral reactivation relay model for multiple sclerosis.
To explain the sequence of viral reactivations in MS pathogenesis.
To offer a new framework for understanding MS and developing therapies.

Main Methods:

The study proposes a theoretical model based on existing evidence.
It integrates findings from virology, immunology, and neurology.
No new experimental data was generated; this is a conceptual model.

Main Results:

The proposed model posits that Epstein-Barr virus (EBV) reactivation in the brain precedes Human Herpesvirus 6A (HHV-6A) reactivation in oligodendrocytes and neurons.
This sequence may lead to relapsing-remitting MS (RRMS) characterized by viral outbreaks, CD8+ T-cell responses, and inflammation.
Self-targeting antibodies may arise, potentially marking the onset of progressive MS in some patients.

Conclusions:

This new model harmonizes diverse evidence related to MS.
It suggests a specific order of viral reactivation events in MS.
The model provides a testable hypothesis and direction for future MS research and therapeutic strategies.